Interaction of HLA-DRB1*1501 allele and TNF-alpha-308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis

被引:14
|
作者
Shahbazi, Majid [1 ]
Roshandel, Danial [1 ]
Omidnyia, Eskandar [2 ]
Rshaidbaghan, Azam [1 ]
机构
[1] Univ Med Sci, Talghani Children Hosp Golestan, Med Cellular & Mol Res Ctr, Gorgon 4916668197, Iran
[2] Pasteur Inst Iran, Dept Biochem, Tehran, Iran
关键词
Multiple sclerosis; Genetic susceptibility; Tumor necrosis factor-alpha; HLA-DRB1*1501; Gene-gene interaction; TUMOR-NECROSIS-FACTOR; ALPHA TNF-ALPHA; SYSTEMIC LUPUS-ERYTHEMATOSUS; GENE POLYMORPHISMS; PROMOTER POLYMORPHISM; RHEUMATOID-ARTHRITIS; MONONUCLEAR-CELLS; IRANIAN PATIENTS; OPTIC NEURITIS; ASSOCIATION;
D O I
10.1016/j.clim.2011.02.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis is a multifactorial disorder with complex genetic basis. It is believed that genes encoding HLA molecule and cytokines are involved in the pathogenesis of MS. In this study, we have evaluated the impact of HLA-DRB1*1501 allele and TNF-alpha - 308 G/A single nucleotide polymorphism, and their interaction, in the susceptibility to MS in Iranian population. Genomic DNA samples were prepared from whole blood of 366 MS Patients and 414 control subjects. The genotypes were determined by SSP-PCR method. Frequency of alleles and genotypes were compared between the two groups by using Fisher's exact test. HLA-DRB1*1501 allele was more frequent among patients (OR=1.57, P=0.0026). TNF-alpha - 308 G allele and G/G genotype had higher frequency among MS patients than control subjects (G vs. A: OR=1.26, P<0.05); G/G vs. A/A: OR = 4.59, P=0.0003). The odds ratio was higher among HLA-DRB1*1501 positive individuals. Co-existence of TNF G and HLA-DRB1*1501 alleles showed higher prevalence among MS patients (OR=7.07, P=0.0007). Our results have shown that HLA-DRB1*1501 allele and TNF-alpha - 308 G/A polymorphism are associated with the risk of multiple sclerosis in Iranian population. We also observed an interaction between these two loci that support the role of HLA alleles and cytokine genes and gene-gene interaction in the development and pathogenesis of MS. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 50 条
  • [21] HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia
    Wu, Jing-Shan
    James, Ian
    Qiu, Wei
    Castley, Alison
    Christiansen, Frank T.
    Carroll, William M.
    Mastaglia, Frank L.
    Kermode, Allan G.
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 219 (1-2) : 109 - 113
  • [22] The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females
    Paradela, Eduardo R.
    Alves-Leon, Soniza V.
    Figueiredo, Andre L. S.
    Pereira, Valeria C. S. R.
    Malfetano, Fabiola
    Mansur, Leticia F.
    Scherpenhuijzen, Simone
    Agostinho, Luciana A.
    Rocha, Catielly F.
    Rueda-Lopes, Fernanda
    Gasparetto, Emerson
    Paiva, Carmen L. A.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2015, 73 (04) : 283 - 288
  • [23] Relationship between HLA-DRB1*11/15 genotype and susceptibility to multiple sclerosis in IRAN
    Abolfazli, Roya
    Samadzadeh, Sara
    Sabokbar, Tayebeh
    Siroos, Bahaadin
    Armaki, Saeed Azad
    Aslanbeiki, Bahram
    Ghelman, Mohsen
    Taheri, Taher
    Shakoori, Abbas
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 345 (1-2) : 92 - 96
  • [24] HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population
    Toro, Jaime
    Cuellar-Giraldo, David
    Diaz-Cruz, Camilo
    Burbano, Lisseth-Estefania
    Guio, Claudia-Marcela
    Reyes, Saul
    Cortes, Fabian
    Cardenas-Robledo, Simon
    Narvaez, Diana M.
    Cardenas, Wilmer
    Porras, Alexandra
    Lattig, Maria-Claudia
    Groot de Restrepo, Helena
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [25] Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia
    Wu, Jing-Shan
    Qiu, Wei
    Castley, Alison
    James, Ian
    Mastaglia, Frank L.
    Christiansen, Frank T.
    Carroll, William M.
    Joseph, Joyce
    Kermode, Allan G.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (01) : 15 - 20
  • [26] A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis
    Xiao, Di
    Ye, Xingguang
    Zhang, Na
    Ou, Meiling
    Guo, Congcong
    Zhang, Baohuan
    Liu, Yang
    Wang, Man
    Yang, Guang
    Jing, Chunxia
    SCIENTIFIC REPORTS, 2015, 5
  • [27] A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients
    Ban, M
    Sawcer, SJ
    Heard, RNS
    Bennetts, BH
    Adams, S
    Booth, D
    Perich, V
    Setakis, E
    Compston, A
    Stewart, GJ
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 143 (1-2) : 60 - 64
  • [28] Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis
    Ferreira Vasconcelos, Claudia Cristina
    Fernandez, Oscar
    Leyva, Laura
    Santos Thuler, Luiz Claudio
    Papais Alvarenga, Regina Maria
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 214 (1-2) : 101 - 103
  • [29] The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population
    Silva, Ana Martins
    Pereira, Clara
    Bettencourt, Andrela
    Carvalho, Cldudia
    Couto, Ana Rita
    Leite, Maria Isabel
    Marta, Monica
    Freijo, Marta
    Costa, Paulo Pinho
    Mendonca, Denisa
    Monteiro, Luis
    Armas, Jdcome Bruges
    Martins, Berta
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 258 (1-2) : 69 - 74
  • [30] HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis
    Cournu-Rebeix, I.
    Genin, E.
    Leray, E.
    Babron, M-C
    Cohen, J.
    Gout, C.
    Alizadeh, M.
    Perdry, H.
    Semana, G.
    Brassat, D.
    Clerget-Darpoux, F.
    Yaouanq, J.
    Edan, G.
    Rosenheim, M.
    Fontaine, B.
    GENES AND IMMUNITY, 2008, 9 (06) : 570 - 574